← Insider buys
ODT

Odonate Therapeutics, Inc.

CEO and 10% owner Kevin C Tang bought $2.3M of Odonate Therapeutics, Inc.

Bought$2,335,217
$24.92Price
93,692Shares
+1%Stake

What ODT did for a copier

Prices for ODT after this filing aren't in yet.

Kevin C Tang's record

6 other buys with 3 months of prices since 2016: on average +1.2% against the S&P 500, and 2 of 6 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Mon, Jun 3. Filed Wed, Jun 5, 1:41 PM ET, during the session. Not investment advice.